Replies to post #8949 on GTC Biotherapeutics (fka GTCB)

[MTB]

Hi Gravity,

A great thought -- which would help moderate the risk/invasiveness of administering ATIII, while helping to more directly target the lymphatics.

That said, 1) I'm hoping IV ATIII will prove effective in DIC, and 2)if not, the above might be purely academic because GTCB might not be around to try it!

Rain in Boston, and bad weather on Mt. Washington. Tomorrow will be the climbing day . . .

Best,
MTB